Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypertension, Essential Hypertension”

749 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 749 results

Early research (Phase 1)Study completedNCT00938197
What this trial is testing

Evaluate the Pharmacokinetic Drug Interaction After Oral Concurrent Administration of Fimasartan and Amlodipine in Healthy Male Volunteers

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 34
Post-approval studies (Phase 4)Study completedNCT03538327
What this trial is testing

Effects of Silybin in Hypertensive Patients

Who this might be right for
Hypertension
University Magna Graecia 50
Early research (Phase 1)Looking for participantsNCT07191899
What this trial is testing

To Evaluate the Efficacy and Safety of KN060 in Essential Hypertension

Who this might be right for
Hypertension
Suzhou Alphamab Co., Ltd. 60
Large-scale testing (Phase 3)Study completedNCT00529451
What this trial is testing

Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg

Who this might be right for
Hypertension
Novartis 1,613
Large-scale testing (Phase 3)Study completedNCT02072330
What this trial is testing

Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.

Who this might be right for
Grade I or II Essential Hypertension
Takeda 353
Post-approval studies (Phase 4)Study completedNCT01755572
What this trial is testing

Blood Pressure Outcomes With Liraglutide Therapy

Who this might be right for
Type 2 DiabetesSystolic Hypertension
Mount Sinai Hospital, Canada 22
Early research (Phase 1)Study completedNCT06744439
What this trial is testing

Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-3 and BR1015-2 Under Fed Conditions

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 49
Post-approval studies (Phase 4)UnknownNCT05165251
What this trial is testing

Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic Hypertension

Who this might be right for
Isolated Systolic Hypertension
Shanghai Jiao Tong University School of Medicine 480
Not applicableUnknownNCT03708601
What this trial is testing

Prognostic Risk of Patients With Essential Hypertension for Cardiovascular Events (PROSPECT)

Who this might be right for
Essential Hypertension
Beijing Institute of Heart, Lung and Blood Vessel Diseases 3,000
Large-scale testing (Phase 3)Study completedNCT00102141
What this trial is testing

Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women

Who this might be right for
HypertensionPostmenopause
Bayer 750
Not applicableUnknownNCT00913094
What this trial is testing

Bioimpedance Evaluation of Therapeutic Titration in Essential, Refractory Hypertension

Who this might be right for
Hypertension
CardioDynamics 200
Testing effectiveness (Phase 2)Study completedNCT02419235
What this trial is testing

The Effect of a Homoeopathic Complex on Blood Pressure in Refractory Hypertension

Who this might be right for
Essential Hypertension
University of Johannesburg 30
Large-scale testing (Phase 3)Study completedNCT00151827
What this trial is testing

Olmesartan Medoxomil in Hypertension and Renal Impairment

Who this might be right for
Essential HypertensionRenal Impairment
Sankyo Pharma Gmbh 393
Large-scale testing (Phase 3)Study completedNCT02177448
What this trial is testing

BIBR 277 Capsule in Patients With Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 225
Not applicableStudy completedNCT05086549
What this trial is testing

An Observation Study to Evaluate the Renoprotective Effect of Fimasartan in Patients With DKD and Proteinuria

Who this might be right for
Diabetic Kidney DiseaseProteinuriaHypertension,Essential
Boryung Pharmaceutical Co., Ltd 360
Large-scale testing (Phase 3)Study completedNCT01299376
What this trial is testing

MK-0954E Phase III Long-Term Study in Participants With Hypertension (MK-0954E-356)

Who this might be right for
Hypertension
Merck Sharp & Dohme LLC 286
Not applicableUnknownNCT06090617
What this trial is testing

Water and Electrolytes Content in HYpertension (WHYSKI) in the SKIn

Who this might be right for
HyperaldosteronismHypertensionAldosterone-producing Adenoma+5 more
University Hospital Padova 35
Testing effectiveness (Phase 2)Study completedNCT00768560
What this trial is testing

Nifedipine (Adalat CR, BAY A1040) High Dose PK/PD Study

Who this might be right for
Hypertension
Bayer 35
Not applicableStudy completedNCT01562613
What this trial is testing

A Blood Pressure Regulation and Stroke Risk Evaluation Study in Hypertensive Patients Treated With Eprosartan

Who this might be right for
HypertensionStroke
Abbott 533
Early research (Phase 1)Study completedNCT06884085
What this trial is testing

Compare to PK Characteristics and Safety Profiles Between AD-227 and Co-administration of AD-227A and AD-227B

Who this might be right for
Primary Hypertension
Addpharma Inc. 70
Next Page